Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00023807

Trial Description

start of 1:1-Block title

Title

COVID-19 pandemic and breast cancer management: An observational clinical study from Pakistan

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

COVID-19 outbreak has adversely affected care of breast cancer patients world-wide. There is paucity of available data on cancer management in lower-middle income countries during this pandemic, we sought to determine the institutional approach towards management of breast cancer patients and the outcomes during COVID-19 pandemic at our institution

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Background: COVID-19 outbreak has adversely affected care of breast cancer patients world-wide. There is paucity of available data on cancer management in lower-middle income countries during this pandemic, we sought to determine the institutional approach towards management of breast cancer patients and the outcomes during COVID-19 pandemic at our institution.
Materials and Methods: Clinicopathological and treatment record of cancer patients who presented to the Breast Clinic from 15th March to 31st July 2020 was retrieved from the institutional database for this retrospective clinical observational study.
Results: A total of 112 patients were qualified for the analysis in which 66 patients (58.9%) underwent breast cancer surgeries. Only 7 of them (10.6%) were identified to be COVID-19 virus positive on routine pre-operative RT-PCR test before elective surgeries. All were asymptomatic, received home-based care via telecommunication and were operated at a later date when test turned out negative. None of them developed any complications post-operatively. Another group of 44 patients (39.3%) were referred for Neoadjuvant/ Systemic chemotherapy in which COVID-19 infection was detected in only 3 patients (6.8%). Two patients shown symptoms of cough and fever hence hospitalised but were not candidates for Intensive Care Unit admission while the third patient was asymptomatic and isolated at home. All patients recovered well and chemotherapy was commenced again after negative RT-PCR test. No mortality was observed.
Conclusion: Despite of being a global crisis particularly for cancer patients we managed to keep infectivity, complications and fatality much lower among breast cancer cases

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

No

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00023807
  •   2020/12/10
  •   [---]*
  •   yes
  •   No approval required according to EC
  •   2020-5418-14043, Aga Khan University (ERC)Pakistan
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   COVID-19
  •   C50 -  Malignant neoplasm of breast
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Patients with Breast cancer presented from March 15 2020 to July 30 20220 were tested for COVID-19 subsequently data was collected on Proforma.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Treatment
  •   Single (group)
  •   N/A
  •   No
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

COVID 19 Infectivity and associated complications in breast cancer cases.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Overall outcome of breast cancer patients

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Pakistan
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2020/03/14
  •   112
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   23   Years
  •   72   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

All Breast cancer patients who presented to Breast Clinic from 15th March to 31st July 2020 which either underwent surgery or referred for Neoadjuvant treatment were included.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Those patients with incomplete medical records or lost to follow-up were excluded from the analysis

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Aga Khan University
    • Ms.  Assistant Professor  Lubna  Vohra 
    • National Stadium Rd, Aga Khan University Hospital, Karachi, Pakistan.
    • 74000  Karachi
    • Pakistan
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Aga khan University
    • Mr.  Dr  Dua  Jabeen 
    • Rafiqui H.J، Iqbal Shaheed Rd, Karachi Cantonment, Karachi,
    • 75850  Karachi
    • Pakistan
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Aga Khan University
    • Ms.  DR  Narmeen  Asif 
    • National Stadium Rd, Aga Khan University Hospital, Karachi, Pakistan.
    • 74000  Karachi
    • Pakistan
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Aga Khan University Hospital
    • Ms.  Assistant Professor  Lubna  Vohra 
    • National Stadium Rd, Aga Khan University Hospital, Karachi, Pakistan.
    • 75850  Karachi
    • Pakistan
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2020/10/03
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.